Relation of the magnitude of blood enzyme elevation to severity of exocrine pancreatic disease.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000681:Amylases / Q000097:blood*; D002766:Cholecystokinin / Q000494:pharmacology; D002908:Chronic Disease; D004796:Clinical Enzyme Tests; D005260:Female; D006801:Humans; D008049:Lipase / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009020:Morphine / Q000494:pharmacology; D009388:Neostigmine / Q000494:pharmacology; D010179:Pancreas / Q000187:drug effects / Q000201:enzymology; D010182:Pancreatic Diseases / Q000175:diagnosis*; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000201:enzymology; D010195:Pancreatitis / Q000175:diagnosis / Q000201:enzymology; D012633:Secretin / Q000494:pharmacology; D013268:Stimulation, Chemical; D013997:Time Factors; D014357:Trypsin / Q000097:blood*
D012633:Secretin; D009388:Neostigmine; D009020:Morphine; D002766:Cholecystokinin; D008049:Lipase; D000681:Amylases; D014357:Trypsin